This inventor holds 1 USPTO granted patent. Top assignees: Japan Immunoresearch Laboratories Co., Ltd., Sekisui Chemical Co., Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Masato Sakurai
Introduction
Masato Sakurai is a notable inventor based in Naganohara-machi, Japan. He has made significant contributions to the field of medical treatment, particularly in addressing inflammatory diseases. His innovative approach has the potential to change the way such conditions are managed.
Latest Patents
Masato Sakurai holds a patent for a method of treating inflammatory diseases. This method involves making peripheral blood from a patient suffering from an inflammatory disease come into contact with a carrier that has a higher affinity for inflammation-associated cells than for lymphocytes. The treated blood is then returned to the patient. This invention allows for prompt treatment of inflammatory diseases without the need for drug therapy, thereby minimizing adverse side effects for patients. He has 1 patent to his name.
Career Highlights
Throughout his career, Masato Sakurai has worked with reputable companies, including Japan Immunoresearch Laboratories Co., Ltd. and Sekisui Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Masato Sakurai has collaborated with notable individuals in his field, including Nobuhito Kashiwagi and Syojiroh Asakura. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Masato Sakurai's innovative methods for treating inflammatory diseases highlight his significant contributions to medical science. His work exemplifies the potential of inventive solutions in improving patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile